Skip to main content

Tag Health & medicine

Protective protein may hold key to halting progression of neurological diseases

January 11, 2005

Patients who suffer from neurological diseases such as Huntington's disease, Parkinson's, Lou Gehrig's disease (ALS) and Alzheimer's disease have dramatically different symptoms. An Alzheimer's patient, for instance, will lose memory and cognitive function, while an ALS sufferer will gradually lose motor control.

Discovery may halt progression of Alzheimer’s

September 2, 2004

In a finding that may cause a dramatic shift in the way scientists and researchers search for a therapy for Alzheimer's disease, a team of researchers led by Jeff Johnson, an associate professor at the School of Pharmacy, has discovered that increased expression of a protein called transthyretin in the brain appears to halt the progression of the disease. The findings appear in the current issue of The Journal of Neuroscience.

ES cell model could provide clues to causes, cures for diabetes

July 28, 2003

By studying embryonic stem cells from a mouse, researchers at UW–Madison have identified a potential model system for elucidating the stages of normal pancreatic development, as well as for developing a much-needed source of insulin-producing cells for the millions of people who need them to treat their diabetes.

Obesity, smoking and inactivity top health concerns

January 14, 2003

In a recent informal poll of UW Health primary care experts, obesity, smoking and inactivity were ranked the health problems most patients need to take seriously. Depression, diabetes and hypertension were not far behind. The good news: tackling even one of these problems will likely improve your health in several areas.

Subtract a gene and feasting mice add no fat

August 13, 2002

Scientists have created an animal that can eat a rich, high-fat diet without adding weight or risking the complications of diabetes

New Alzheimer’s study to focus on children

January 29, 2002

As the number of new Alzheimer's cases balloons to a projected 14 million by 2050, the Medical School is establishing the nation's first comprehensive research study of children of people with Alzheimer's disease.

Disarming Alzheimer’s Toxic Proteins

April 14, 1997

A new study of the proteins that may be responsible for the brain lesions associated with Alzheimer's disease promises a new understanding of its underlying cause, and may someday yield new treatments for the devastating and deadly disease.